-
1
-
-
84926336826
-
Congenital myasthenic syndromes: Pathogenesis, diagnosis, and treatment
-
Engel AG, Shen X, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol 2015;14:420-434.
-
(2015)
Lancet Neurol
, vol.14
, pp. 420-434
-
-
Engel, A.G.1
Shen, X.2
Selcen, D.3
Sine, S.M.4
-
2
-
-
84908236633
-
Synaptotagmin 2 mutations cause an autosomal-dominant form of Lambert-Eaton myasthenic syndrome and nonprogressive motor neuropathy
-
Herrmann DN, Horvath R, Sowden JE, et al. Synaptotagmin 2 mutations cause an autosomal-dominant form of Lambert-Eaton myasthenic syndrome and nonprogressive motor neuropathy. Am J Hum Genet 2014;95:332-339.
-
(2014)
Am J Hum Genet
, vol.95
, pp. 332-339
-
-
Herrmann, D.N.1
Horvath, R.2
Sowden, J.E.3
-
3
-
-
84924120978
-
Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability
-
Shen XM, Selcen D, Brengman J, Engel AG. Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability. Neurology 2014;83: 2247-2255.
-
(2014)
Neurology
, vol.83
, pp. 2247-2255
-
-
Shen, X.M.1
Selcen, D.2
Brengman, J.3
Engel, A.G.4
-
4
-
-
10744231003
-
The vesicular amine transporter family (SLC18): Amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine
-
Eiden LE, Schafer MK, Weihe E, Schutz B. The vesicular amine transporter family (SLC18): Amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine. Pflugers Arch 2004;44:636-640.
-
(2004)
Pflugers Arch
, vol.44
, pp. 636-640
-
-
Eiden, L.E.1
Schafer, M.K.2
Weihe, E.3
Schutz, B.4
-
5
-
-
84875155393
-
SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine
-
Lawal HO, Krantz DE. SLC18: vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med 2013;34:360-372.
-
(2013)
Mol Aspects Med
, vol.34
, pp. 360-372
-
-
Lawal, H.O.1
Krantz, D.E.2
-
6
-
-
84903906687
-
Whole exome sequencing identifies three recessive FIG4 mutations in an apparently dominant pedigree with Charcot-Marie-Tooth disease
-
Menezes MP, Waddell L, Lenk GM, et al. Whole exome sequencing identifies three recessive FIG4 mutations in an apparently dominant pedigree with Charcot-Marie-Tooth disease. Neuromuscul Disord 2014;24:666-670.
-
(2014)
Neuromuscul Disord
, vol.24
, pp. 666-670
-
-
Menezes, M.P.1
Waddell, L.2
Lenk, G.M.3
-
7
-
-
0035852681
-
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans
-
Ohno K, Tsujino A, Shen XM, et al. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 2001;98:2017-2022.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 2017-2022
-
-
Ohno, K.1
Tsujino, A.2
Shen, X.M.3
-
8
-
-
84887617035
-
A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases
-
Neveling K, Feenstra I, Gilissen C, et al. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat 2013;34:1721-1726.
-
(2013)
Hum Mutat
, vol.34
, pp. 1721-1726
-
-
Neveling, K.1
Feenstra, I.2
Gilissen, C.3
-
9
-
-
84876886933
-
Congenital myasthenic syndromes
-
Dulac O, Lassonde M, Sarnat HB, eds. (3rd Series), Pediatric Neurology, Part III. Amsterdam, The Netherlands: Elsevier B. V.
-
Eymard B, Hanta D, Estournet B. Congenital myasthenic syndromes. In: Dulac O, Lassonde M, Sarnat HB, eds. Handbook of Clinical Neurology (3rd Series), Pediatric Neurology, Part III. Amsterdam, The Netherlands: Elsevier B. V.; 2013;113:1469-1479.
-
(2013)
Handbook of Clinical Neurology
, vol.113
, pp. 1469-1479
-
-
Eymard, B.1
Hanta, D.2
Estournet, B.3
-
10
-
-
84866272011
-
Congenital myasthenic syndromes: Achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: A study of 680 patients
-
Abicht A, Dusl M, Gallenmuller C, et al. Congenital myasthenic syndromes: Achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: A study of 680 patients. Hum Mutat 2012;33: 1474-1484.
-
(2012)
Hum Mutat
, vol.33
, pp. 1474-1484
-
-
Abicht, A.1
Dusl, M.2
Gallenmuller, C.3
-
12
-
-
84857197756
-
Evaluation of neuromuscular junction disorders in the electromyography laboratory
-
Juel VC. Evaluation of neuromuscular junction disorders in the electromyography laboratory. Neurol Clin 2012;30:621-639.
-
(2012)
Neurol Clin
, vol.30
, pp. 621-639
-
-
Juel, V.C.1
-
13
-
-
33748062480
-
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition
-
Prado VF, de Castro BM, Lima RF, et al. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 2006;51:601-612.
-
(2006)
Neuron
, vol.51
, pp. 601-612
-
-
Prado, V.F.1
De Castro, B.M.2
Lima, R.F.3
-
14
-
-
70349305317
-
The vesicular acetylcholine transporter is required for neuromuscular development and function
-
De Castro BM, De Jaeger X, Martins-Silva C, et al. The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol Cell Biol 2009;29:5238-5250.
-
(2009)
Mol Cell Biol
, vol.29
, pp. 5238-5250
-
-
De Castro, B.M.1
De Jaeger, X.2
Martins-Silva, C.3
-
15
-
-
77949342114
-
Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure
-
Lara A, Damasceno DD, Pires R, et al. Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol 2010;30: 1746-1756.
-
(2010)
Mol Cell Biol
, vol.30
, pp. 1746-1756
-
-
Lara, A.1
Damasceno, D.D.2
Pires, R.3
-
16
-
-
84892507477
-
Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction
-
Rodrigues HA, Fonseca Mde C, Camargo WL, et al. Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction. PLoS One 2013;8:e78342.
-
(2013)
PLoS One
, vol.8
, pp. e78342
-
-
Rodrigues, H.A.1
Fonseca Mde, C.2
Camargo, W.L.3
-
17
-
-
77953121725
-
Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations
-
Ulrike S, Christen H, Durmus H, et al. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations. Eur J Ped Neurol 2010;14:326-333.
-
(2010)
Eur J Ped Neurol
, vol.14
, pp. 326-333
-
-
Ulrike, S.1
Christen, H.2
Durmus, H.3
-
18
-
-
84989827976
-
-
DECIPHER Consortium. Accessed June 13, 2015
-
DECIPHER Consortium. DECIPHER. http://decipher. sanger. Ac. uk. Accessed June 13, 2015.
-
DECIPHER
-
-
-
19
-
-
84857688369
-
Recurrent deletions and reciprocal duplications of 10q11. 21q11. 23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats
-
Stankiewicz P, Kulkarni S, Dharmadhikari AV, et al. Recurrent deletions and reciprocal duplications of 10q11. 21q11. 23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Hum Mutat 2011;33:165-179.
-
(2011)
Hum Mutat
, vol.33
, pp. 165-179
-
-
Stankiewicz, P.1
Kulkarni, S.2
Dharmadhikari, A.V.3
-
20
-
-
3042602081
-
Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency
-
Brandon EP. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J Neurosci 2004;24:5459-5466.
-
(2004)
J Neurosci
, vol.24
, pp. 5459-5466
-
-
Brandon, E.P.1
-
22
-
-
84888136157
-
Update in electromyography
-
Pitt M. Update in electromyography. Curr Opin Pediatr 2013;25:676-681.
-
(2013)
Curr Opin Pediatr
, vol.25
, pp. 676-681
-
-
Pitt, M.1
|